These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37124559)

  • 21. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.
    Shimizu W; Makimoto H; Yamagata K; Kamakura T; Wada M; Miyamoto K; Inoue-Yamada Y; Okamura H; Ishibashi K; Noda T; Nagase S; Miyazaki A; Sakaguchi H; Shiraishi I; Makiyama T; Ohno S; Itoh H; Watanabe H; Hayashi K; Yamagishi M; Morita H; Yoshinaga M; Aizawa Y; Kusano K; Miyamoto Y; Kamakura S; Yasuda S; Ogawa H; Tanaka T; Sumitomo N; Hagiwara N; Fukuda K; Ogawa S; Aizawa Y; Makita N; Ohe T; Horie M; Aiba T
    JAMA Cardiol; 2019 Mar; 4(3):246-254. PubMed ID: 30758498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
    Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
    Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome.
    Priori SG; Napolitano C; Cantù F; Brown AM; Schwartz PJ
    Circ Res; 1996 Jun; 78(6):1009-15. PubMed ID: 8635231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.
    Schwartz PJ; Priori SG; Locati EH; Napolitano C; Cantù F; Towbin JA; Keating MT; Hammoude H; Brown AM; Chen LS; Colatsky TJ
    Circulation; 1995 Dec; 92(12):3381-6. PubMed ID: 8521555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
    Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
    Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Ma D; Wei H; Lu J; Huang D; Liu Z; Loh LJ; Islam O; Liew R; Shim W; Cook SA
    Stem Cell Res Ther; 2015 Mar; 6(1):39. PubMed ID: 25889101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
    Shimizu W; Antzelevitch C
    J Am Coll Cardiol; 2000 Mar; 35(3):778-86. PubMed ID: 10716483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome].
    Liu WL; Hu DY; Li P; Li CL; Qin XG; Li YT; Li L; Li ZM; Dong W; Qi Y; Wang Q
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):463-6. PubMed ID: 16831322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
    Priori SG; Cantù F; Schwartz PJ
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
    Tester DJ; Will ML; Haglund CM; Ackerman MJ
    Heart Rhythm; 2005 May; 2(5):507-17. PubMed ID: 15840476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of ion channel gene variants in patients with long QT syndrome.
    Ernesto C; Cruz FE; Lima FS; Coutinho JL; Silva R; Urményi TP; Carvalho AC; Rondinelli E
    Arq Bras Cardiol; 2011 Mar; 96(3):172-8. PubMed ID: 21308345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disrupted Ca
    Kashiwa A; Makiyama T; Kohjitani H; Maurissen TL; Ishikawa T; Yamamoto Y; Wuriyanghai Y; Gao J; Huang H; Imamura T; Aizawa T; Nishikawa M; Chonabayashi K; Mishima H; Ohno S; Toyoda F; Sato S; Yoshiura KI; Takahashi K; Yoshida Y; Woltjen K; Horie M; Makita N; Kimura T
    Heart Rhythm; 2023 Jan; 20(1):89-99. PubMed ID: 36007726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel.
    Chen J; Li H; Guo S; Yang Z; Sun S; Zeng J; Gou H; Chen Y; Wang F; Lin Y; Huang K; Yue H; Ma Y; Lin Y
    Orphanet J Rare Dis; 2022 Oct; 17(1):394. PubMed ID: 36303204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.
    Tian XL; Yong SL; Wan X; Wu L; Chung MK; Tchou PJ; Rosenbaum DS; Van Wagoner DR; Kirsch GE; Wang Q
    Cardiovasc Res; 2004 Feb; 61(2):256-67. PubMed ID: 14736542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice.
    Fabritz L; Kirchhof P; Franz MR; Nuyens D; Rossenbacker T; Ottenhof A; Haverkamp W; Breithardt G; Carmeliet E; Carmeliet P
    Cardiovasc Res; 2003 Mar; 57(4):1085-93. PubMed ID: 12650887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epinephrine bolus test in detecting long QT syndrome mutation carriers with indeterminable electrocardiographic phenotype.
    Hekkala AM; Swan H; Viitasalo M; Väänänen H; Toivonen L
    Ann Noninvasive Electrocardiol; 2011 Apr; 16(2):172-9. PubMed ID: 21496168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits.
    Odening KE; Jung BA; Lang CN; Cabrera Lozoya R; Ziupa D; Menza M; Relan J; Franke G; Perez Feliz S; Koren G; Zehender M; Bode C; Brunner M; Sermesant M; Föll D
    Heart Rhythm; 2013 Oct; 10(10):1533-41. PubMed ID: 23892340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium channel blockers in the management of long QT syndrome types 3 and 2: A system review and meta-analysis.
    Yang Y; Lv TT; Li SY; Zhang P
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3057-3067. PubMed ID: 34427958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.